Marek Wardȩcki (Marek Wardęcki, Marek Wardecki)

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 8

Top Topics

Chronic Obstructive Pulmonary Disease

Toll Like Receptor

Ejection Fraction

Top Venues

American journal of hematology

British journal of haematology

This page only lists publications with an associated author ORCID identifier.

Publications

Bruno Fattizzo, Alexander Röth, Catherine M Broome, Umer Khan, Marek Wardȩcki, Matias Cordoba, Wilma Barcellini
COVID-19 vaccine safety and immunogenicity in patients with cold agglutinin disease receiving concomitant sutimlimab. American journal of hematology 99 (4) (2024)
Bruno Fattizzo, Alexander Röth, Catherine M Broome, Umer Khan, Marek Wardȩcki, Matias Cordoba, Wilma Barcellini
COVID-19 vaccine safety and immunogenicity in patients with cold agglutinin disease receiving concomitant sutimlimab. American journal of hematology 99 (4) (2024)
Bruno Fattizzo, Alexander Röth, Catherine M Broome, Umer Khan, Marek Wardȩcki, Matias Cordoba, Wilma Barcellini
COVID-19 vaccine safety and immunogenicity in patients with cold agglutinin disease receiving concomitant sutimlimab. American journal of hematology (2024)
Bruno Fattizzo, Alexander Röth, Catherine M Broome, Umer Khan, Marek Wardȩcki, Matias Cordoba, Wilma Barcellini
COVID-19 vaccine safety and immunogenicity in patients with cold agglutinin disease receiving concomitant sutimlimab. American journal of hematology 99 (4) (2024)
Alexander Röth, Wilma Barcellini, Shirley D'Sa, Yoshitaka Miyakawa, Catherine M Broome, Marc Michel, David J Kuter, Bernd Jilma, Tor Henrik Anderson Tvedt, Ilene C Weitz, Ronnie Yoo, Deepthi Jayawardene, Deepthi S Vagge, Katarina Kralova, Frank Shafer, Marek Wardȩcki, Michelle Lee, Sigbjørn Berentsen
Sustained inhibition of complement C1s with sutimlimab over 2 years in patients with cold agglutinin disease. American journal of hematology (2023)
Georg Gelbenegger, Ulrich Jaeger, Michael Fillitz, Shirley D'Sa, Ronwyn Cartwright, Frank Shafer, Marek Wardȩcki, Jennifer Wang, Christian Schoergenhofer, Bernd Jilma
Sustained sutimlimab response for 3 years in patients with cold agglutinin disease: A phase I, open-label, extension trial. British journal of haematology 198 (4) (2022)
Alexander Röth, Sigbjørn Berentsen, Wilma Barcellini, Shirley D'Sa, Bernd Jilma, Marc Michel, Ilene C Weitz, Masaki Yamaguchi, Jun-Ichi Nishimura, Josephine M I Vos, Michael Storek, Nancy Wong, Parija Patel, Xiaoyu Jiang, Deepthi S Vagge, Marek Wardȩcki, Frank Shafer, Michelle Lee, Catherine M Broome
Sutimlimab in patients with cold agglutinin disease: results of the randomized placebo-controlled phase 3 CADENZA trial. Blood 140 (9) (2022)
Tor Henrik A Tvedt, Egil Steien, Bente Øvrebø, Rune Haaverstad, William Hobbs, Marek Wardȩcki, Geir Erland Tjønnfjord, Sigbjørn Andreas Berentsen
Sutimlimab, an investigational C1s inhibitor, effectively prevents exacerbation of hemolytic anemia in a patient with cold agglutinin disease undergoing major surgery. American journal of hematology (2021)